[Expectant management of pruritus in pregnant women].
Estève
E
E
Service de dermatologie, CHR Orléans, Hôpital Porte Madeleine.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002780:Cholestasis, Intrahepatic / Q000175:diagnosis / Q000188:drug therapy; D003872:Dermatitis / Q000175:diagnosis / Q000628:therapy; D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects; D005499:Folliculitis / Q000175:diagnosis / Q000188:drug therapy; D005938:Glucocorticoids; D006801:Humans; D010391:Pemphigoid, Bullous / Q000175:diagnosis / Q000628:therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000188:drug therapy*; D011379:Prognosis; D011536:Prurigo / Q000175:diagnosis / Q000188:drug therapy; D011537:Pruritus / Q000175:diagnosis / Q000188:drug therapy*; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D005938:Glucocorticoids